Experimental verification of age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography

Japanese Journal of Radiology

Volumn 28, Issue 2, 2010, Pages 123-131

  Tachibana, Atsushi ^a   Nagasawa, Ayumu ^a   Kitamura, Akihiro ^a   Miyazaki, Shohei ^a   Murase, Kenya ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Age difference; Cisplatin; Dynamic contrast enhanced CT; Nephrotoxicity; Rat

Indexed keywords

CISPLATIN;

ADOLESCENT; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG CLEARANCE; DYNAMIC CONTRAST ENHANCED COMPUTED TOMOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY MASS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; IOPAMIDOL; KIDNEY; KIDNEY DISEASES; MALE; ORGAN SIZE; RADIOGRAPHIC IMAGE ENHANCEMENT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77649223540     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-009-0396-2     Document Type: Article

References (19)

1. R.F. Borch M.E. Pleasants 1979 Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model Proc Natl Acad Sci U S A 76 6611 6614 10.1073/pnas.76.12.6611 1:CAS:528:DyaL3cXmvFKksg%3D%3D 230514 (Pubitemid 10163448)
2. W.J. Hrushesky W. Shimp B.J. Kennedy 1984 Lack of age-dependent cisplatin nephrotoxicity Am J Med 76 579 584 10.1016/0002-9343(84)90280-8 1:STN:280:DyaL2c7ns1Sguw%3D%3D 6538750
3. A. Cubillo M. Cornide J.L. Lopez R. Molina J. Feliu E. Espinosa, et al. 2001 Renal tolerance to cisplatin in patients 70 years and older Am J Clin Oncol 24 192 197 10.1097/00000421-200104000-00018 1:STN:280:DC%2BD3M3jtVOqsg%3D%3D 11319297 (Pubitemid 32323359)
4. J.E. Mollman D.J. Glover W.M. Hogan R.E. Furman 1988 Cisplatin neuropathy: risk factors, prognosis, and protection by WR-2721 Cancer 61 2192 2195 10.1002/1097-0142(19880601)61:11<2192::AID-CNCR2820611110>3.0.CO;2-A 1:STN:280:DyaL1c3htVWqsw%3D%3D 2835140
5. F. Oshita T. Kurata T. Kasai M. Fukuda N. Yamamoto Y. Ohe, et al. 1995 Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions Jpn J Cancer Res 86 1198 1202 1:CAS:528:DyaK28XnsFOmtg%3D%3D 8636010
6. H.T.M. Jongejan A.P. Provoost E.D. Wolff J.C. Molenaar 1986 Nephrotoxicity of cis-platin comparing young and adult rats Pediatr Res 20 9 14 10.1203/00006450-198601000-00003 1:CAS:528:DyaL28XotFKgsg%3D%3D 3945520
7. D. Appenroth K. Winnefeld H. Braunlich 1988 Nephrotoxicity and pharmacokinetics of cisplatinum in young and adult rats Biomed Biochim Acta 47 791 797 1:CAS:528:DyaL1cXlvVejs78%3D 3240309 (Pubitemid 18253996)
8. Y. Tsushima 1999 Functional CT of the kidney Eur J Radiol 30 191 197 10.1016/S0720-048X(99)00011-X 1:STN:280:DyaK1MznvFOrtA%3D%3D 10452717 (Pubitemid 29343736)
9. M.J. Blomley R. Coulden C. Bufkin M.J. Lipton P. Dawson 1993 Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion Invest Radiol 28 suppl5 S72 S77 8282508
10. P. Dawson A.M. Peters 1993 Dynamic contrast bolus computed tomography for the assessment of renal function Invest Radiol 28 1039 1042 10.1097/00004424-199311000-00014 1:STN:280:DyaK2c7gt12nug%3D%3D 8276575 (Pubitemid 24085696)
11. Murase K, Kitamura A, Tachibana A, Kusakabe Y, Matsuura, Miyazaki S. Quantitative assessment of early experimental diabetes in rats using dynamic contrast-enhanced computed tomography. Eur J Radiol 2009 Apr 3. [Epub ahead of print]
12. C.S. Patlak R.G. Blasberg J.D. Fenstermacher 1983 Graphical evaluation of blood-to-brain barrier transfer constants from multiple-time uptake data J Cereb Blood Flow Metab 3 1 7 1:STN:280:DyaL3s7gvFegtA%3D%3D 6822610
13. A. Cenic D.G. Nabavi R.A. Craen A.W. Gelb T.Y. Lee 1999 Dynamic CT measurement of cerebral blood flow: a validation study AJNR Am J Neuroradiol 20 63 73 1:STN:280:DyaK1M7jvFKguw%3D%3D 9974059
14. K. Murase A. Tachibana Y. Kusakabe R. Matsuura S. Miyazaki 2008 A method for quantitative assessment of renal function using dynamic contrast-enhanced computed tomography: evaluation of drug-induced nephrotoxicity in rats Med Phys 35 5768 5776 10.1118/1.3020595 1:CAS:528:DC%2BD1cXhsVentbbI 19175134
15. C. Fleck 1999 Determination of the glomerular filtration rate (GFR): methodological problems, age-dependence, consequences of various surgical interventions, and the influence of different drugs and toxic substances Physiol Res 48 267 279 1:STN:280:DC%2BD3c7gt1aitA%3D%3D 10638678
16. Cameron JS. Renal function testing. In: Cameron JS, Davison AM, Grunfeld JP, Kerr D, Ritz E, editors. Oxford textbook of clinical nephrology. Oxford: Oxford University Press; 1992. p. 24-71.
17. B.H. Ali M. Al-Moundhri M. Tageldin I.S. Al Husseini M.A. Mansour A. Nemmar, et al. 2008 Ontogenic aspects of cisplatin-induced nephrotoxicity in rats Food Chem Toxicol 46 3355 3359 10.1016/j.fct.2008.07.030 1:CAS:528:DC%2BD1cXhtlalsrnJ 18790000
18. K. Nakata M. Kawase S. Ogino C. Kinoshita H. Murata T. Sakaue, et al. 1996 Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives Mech Ageing Dev 90 195 207 10.1016/0047-6374(96)01771-X 1:CAS:528:DyaK28XmsVSks74%3D 8898313 (Pubitemid 26331619)
19. Y. Kawai S. Taniuchi S. Okahara M. Nakamura M. Gemba 2005 Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation Biol Pharm Bull 28 1385 1388 10.1248/bpb.28.1385 1:CAS:528:DC%2BD2MXhtVWrsrzL 16079479 (Pubitemid 41379685)